TrialJournal of attention disorders2020

A Phase II Double-Blind, Placebo-Controlled, Efficacy and Safety Study of SPN-812 (Extended-Release Viloxazine) in Children With ADHD.

Janet K Johnson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.